China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparative Analysis of the Efficacy and Safety of Nafamostat Mesylate and Unfractionat... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, Phase II clinical study of camrelizumab combined with anlotinib as second... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Longitudinal Mixed-Methods Study on the Dual Trajectories of Body Image and Self-Comp... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of Liposomal Bupivacaine versus Plain Bupivacaine for Ultrasound-Guided Erec... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Exploring the mechanism of carvedilol in the treatment of liver cirrhosis using multiom... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Different saline injection methods superficial to the anterior scalene muscle for phren... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Accuracy and Consistency of the Smart Belt Health Assessment System and Balance Assessm... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analgesic efficacy of diluted nitrous oxide on patients with maxillofacial trauma'. The... Read More
China, Sept. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Posterior nasal neurectomy for type 2 chronic rhinosinusitis with nasal polyps complica... Read More
Singapore, Sept. 1 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy o... Read More